Assemblée générale Projet OASIS (programme de recherche européen pour optimiser les anticorps conjugués) Gustave Roussy

8h30: Welcoming participants
8h50-9h20: External expert lecture,
09h20-09h50: Project overview, Barbara Pistilli, Project Coordinator, Gustave Roussy
09h50-10h20: Project management & Communication (WP16-20), Laura Lauden and Noémie Corcos,Gustave Roussy
10h20-10h40: Patient Engagement (WP16), Kaustubh Dhurandhar, CPE
10h40-11h: Exploitation (WP17), Jérome Gaborit, GRT
Coffee break
11h30-12h: Clinical Data sets (WP1-WP2), Jerome Lemonnier & Marjorie Mauduit, Unicancer
12h-12h15: Digital pathology predictors of response (WP4), Maria Vakalopoulo, Centrale Supélec
12h15-12h45: Liquid biopsy predictors of response (WP3), Marianne Ouhlen, Gustave Roussy; Marijana Rucevic, Olink; Evi Lianidou, NKUA
12h45-13h00: Predicting ADCs toxicity by proteomics and pharmacodynamics analysis (WP9), Angelo Paci, Gustave Roussy
Lunch Break
14h-14h15: ImmunoPET HER Breast (WP5), Geraldine Gebhardt, Loubna Taraji, Institut Jules Bordet
14h15-14h35: Feasability ImmunoPET TROP-2, Nectin-4 (WP6), and production of radiolabeled Ab and ADC (WP10) Charles Truillet, CEA
14h35-14h50: Characterisation of tumor microenvironment and intrinsic pathways of resistance (WP7- WP8), Guillaume Montagnac, INSERM
14h50-15h05: Generation of PDOs biobank and discovery (WP11-WP12), Mathieu Raul, Orakl and Noémie Corcos, Gustave Roussy
15h05-15h25: AI-multimodal training, evaluation and interpretability (WP13,) External validation of OASIS Score (WP14), Paul-Henry Cournède, CentraleSupélec
Coffee break
16h00-16h30: Closing remarks and next steps, Barbara Pistilli and Noemie Corcos